


| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Fibrinogen, human | Change notification | 27.02.2026 | Production problem | Haemocomplettan P 2g | |
| Fibrinogen, human | Change notification | 27.02.2026 | Production problem | Haemocomplettan P 1g | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Initial report | 27.02.2026 | Other | Atorvastatin Micro Labs 80 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 27.02.2026 | Other | Atorvastatin Micro Labs 30 mg film-coated tablets | |
| Efavirenz; emtricitabine; tenofovir disoproxil | Initial report | 27.02.2026 | Production problem | Efavirenz/emtricitabine/tenofovir disoproxil Heumann 600 mg/200 mg/245 mg film-coated tablets | |
| Mesalazine | Initial report | 27.02.2026 | Other | Asacol 1600 mg modified-release tablet | |
| Arsenic(III) oxide | Change notification | 27.02.2026 | Other | TRISENOX 2 mg/ml concentrate for solution for infusion | |
| Valaciclovir hydrochloride | Change notification | 27.02.2026 | Other | Valaciclovir – 1A Pharma 500 mg film-coated tablets | |
| Dexketoprofen trometamol | Change notification | 27.02.2026 | Production problem | Sympal inject 50 mg solution for injection/infusion | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 27.02.2026 | Production problem | Quetiapine – 1 A Pharma 400 mg prolonged-release tablets | |
| Rifampicin sodium | Change notification | 27.02.2026 | Other | Eremfat i.v. 600mg | |
| Oxcarbazepine | Change notification | 27.02.2026 | Other | Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension | |
| Imiquimod | Initial report | 27.02.2026 | Other | AKSUNIM 50 mg/g cream | |
| Oxytocin | Change notification | 27.02.2026 | Production problem | Oxytocin 3 I.E. Hexal | |
| Esomeprazole hemimagnesium | Change notification | 26.02.2026 | Production problem | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules | |
| Esomeprazole hemimagnesium | Change notification | 26.02.2026 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules | |
| Ezetimibe; simvastatin | Change notification | 26.02.2026 | Production problem | EZETIMIBE/SIMVA BASICS 10 mg/10 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 26.02.2026 | Production problem | EZETIMIBE/SIMVA BASICS 10 mg/20 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 26.02.2026 | Production problem | EZETIMIBE/SIMVA BASICS 10 mg/40 mg tablets | |
| Ezetimibe; simvastatin | Change notification | 26.02.2026 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/80 mg tablets | |
| Isotretinoin | Change notification | 26.02.2026 | Other | ISOTRETINOIN BASICS 20 mg soft capsules | |
| Isotretinoin | Change notification | 26.02.2026 | Other | ISOTRETINOIN BASICS 10 mg soft capsules | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 26.02.2026 | Other | CIPRO BASICS 250 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 26.02.2026 | Other | CIPRO BASICS 750 mg film-coated tablets | |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 26.02.2026 | Other | CIPRO BASICS 500 mg film-coated tablets | |
| Candesartan cilexetil | Change notification | 26.02.2026 | Other | CANDESARTAN BASICS 8 mg tablets | |
| Candesartan cilexetil | Change notification | 26.02.2026 | Other | CANDESARTAN BASICS 4 mg tablets | |
| Candesartan cilexetil | Change notification | 26.02.2026 | Other | CANDESARTAN BASICS 32 mg tablets | |
| Candesartan cilexetil | Change notification | 26.02.2026 | Other | CANDESARTAN BASICS 16 mg tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 26.02.2026 | Other | ATORVASTATIN BASICS 30 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 26.02.2026 | Other | ATORVASTATIN BASICS 40 mg film-coated tablets | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 26.02.2026 | Other | ATORVASTATIN BASICS 80 mg film-coated tablets | |
| Tobramycin | Initial report | 26.02.2026 | Other | Tobramycin SUN 300 mg solution for nebulizer | |
| Lacosamide | Change notification | 26.02.2026 | Other | Vimpat 100 mg film-coated tablets – OP14 | |
| Hydrochlorothiazide; Losartan potassium | Initial report | 26.02.2026 | Other | LosarHCT-Denk 50 mg/12.5 mg film-coated tablets | |
| Imatinib mesylate | Change notification | 26.02.2026 | Other | Imatinib Denk 100 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 26.02.2026 | Other | Seroquel Prolong 200 mg prolonged-release tablets | |
| Clonidine hydrochloride | Initial report | 26.02.2026 | Other | Catapresan 150 | |
| Paliperidone palmitate | Change notification | 26.02.2026 | Other | Niapelf | |
| Sodium valproate; valproic acid | Initial report | 26.02.2026 | Other | Valpro AL 300 mg prolonged-release tablets | |
| Eletriptan hydrobromide | Initial report | 26.02.2026 | Production problem | Eletriptan Bluefish 20 mg film-coated tablets | |
| Alanine; Arginine; Glycine; Histidine; Isoleucine; Leucine; Lysine acetate; Methionine; Phenylalanine; Proline; Serine; Taurine; Threonine; Tryptophan; Tyrosine; Valine | Initial report | 26.02.2026 | Other | Aminoven 10% | |
| Acetylcysteine; alanine; arginine; acetic acid 99%; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; phenylalanine; proline; serine; threonine; tryptophan; valine | Initial report | 26.02.2026 | Other | Aminosteril N-Hepa 8% | |
| Acetylcysteine; alanine; arginine; glycine; histidine; isoleucine; L-malic acid; leucine; lysine acetate; methionine; N-acetyl tyrosine (Ph.Eur.); phenylalanine; proline; serine; taurine; threonine; tryptophan; valine | Initial report | 26.02.2026 | Other | Aminoven infant 10% | |
| Prednisolone | Initial report | 26.02.2026 | Other | Prednisolone AL 20 mg tablets | |
| Nilotinib hydrochloride dihydrate | Initial report | 26.02.2026 | Other | Nilotinib AL 50 mg hard capsules | |
| Calcium folinate hydrate | Change notification | 26.02.2026 | Production problem | Calcium folinate onkovis 10 mg/ml solution for injection | |
| Rosuvastatin hemicalcium | Change notification | 25.02.2026 | Other | Rosuvastatin Aristo 5 mg film-coated tablets | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) | Change notification | 25.02.2026 | Other | Dexafluid 1 mg/ml eye drops | |
| Betamethasone dipropionate (Ph.Eur.); calcipotriol monohydrate | Initial report | 25.02.2026 | Other | Calcipotriol comp. 50 micrograms/g + 0.5 mg/g gel | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 600 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 400 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 300 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 200 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 150 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Quetiapine-neuraxpharm 50 mg prolonged-release tablets | |
| Propranolol hydrochloride | Initial report | 25.02.2026 | Other | Propranolol AL 80 | |
| Pregabalin | Initial report | 25.02.2026 | Other | Pregabalin Aurobindo 200 mg hard capsules | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 25.02.2026 | Other | Seroquel Prolong 150 mg prolonged-release tablets | |
| Risperidone | Initial report | 25.02.2026 | Other | Risperidone Aurobindo 1 mg film-coated tablets | |
| Flutamide | Change notification | 25.02.2026 | Other | Flutamide AL 250 | |
| Sumatriptan succinate | Initial report | 25.02.2026 | Other | Sumatriptan Aurobindo 50 mg tablets | |
| Rizatriptan benzoate | Initial report | 25.02.2026 | Other | Rizatriptan Aurobindo 10 mg tablets | |
| Lamotrigine | Change notification | 25.02.2026 | Production problem | Lamotrigine Aurobindo 5 mg tablets for oral suspension | |
| Dutasteride; tamsulosin hydrochloride | Change notification | 25.02.2026 | Production problem | Dutasteride/tamsulosin PUREN 0.5 mg/0.4 mg hard capsules | |
| Buprenorphine hydrochloride | Change notification | 25.02.2026 | Other | Buprenorphine PUREN 8 mg sublingual tablets | |
| Propranolol hydrochloride | Initial report | 25.02.2026 | Other | Propranolol-CT 80 mg film-coated tablets | |
| Propranolol hydrochloride | Initial report | 25.02.2026 | Other | Propranolol-CT 40 mg film-coated tablets | |
| Arsenic(III) oxide | Change notification | 25.02.2026 | Production problem | Arsenic trioxide STADA 1 mg/ml concentrate for solution for infusion | |
| Tranexamic acid | Change notification | 24.02.2026 | Production problem | Tranexamic acid PUREN 100 mg/ml solution for injection | |
| Risedronate sodium 2.5 hydrate (Ph.Eur.) | Change notification | 24.02.2026 | Other | Risedronate Aurobindo once weekly 35 mg film-coated tablets | |
| Risperidone | Change notification | 24.02.2026 | Other | Risperidone PUREN 3 mg film-coated tablets | |
| Flurazepam | Change notification | 24.02.2026 | Production problem | Flurazepam real | |
| Tropicamide | Change notification | 24.02.2026 | Production problem | Mydriaticum Stulln UD | |
| Quetiapine fumarate (Ph.Eur.) | Initial report | 24.02.2026 | Other | Seroquel Prolong 50 mg prolonged-release tablets | |
| Ritonavir | Change notification | 24.02.2026 | Other | Ritonavir Viatris 100 mg film-coated tablets – OP30 | |
| Ethambutol dihydrochloride | Initial report | 24.02.2026 | Production problem | EMB-FATOL 500 mg | |
| Valaciclovir hydrochloride | Initial report | 24.02.2026 | Production problem | Valaciclovir Aurobindo 500 mg film-coated tablets | |
| Ethambutol dihydrochloride | Initial report | 24.02.2026 | Other | EMB-FATOL 100 mg | |
| Thioctic acid trometamol salt (1:1) | Change notification | 24.02.2026 | Other | Thioctacid 600 T | |
| Telmisartan | Initial report | 23.02.2026 | Other | Telmisartan Micro Labs 20 mg tablets | |
| Entecavir | Initial report | 23.02.2026 | Production problem | Baraclude 0.5 mg film-coated tablets – OP90(90×1) | |
| Doxorubicin hydrochloride | Change notification | 23.02.2026 | Production problem | DOXO-cell 150 mg solution for injection | |
| Doxorubicin hydrochloride | Change notification | 23.02.2026 | Production problem | DOXO-cell 50 mg solution for injection | |
| Mivacurium chloride | Change notification | 23.02.2026 | Production problem | Mivacron 20mg | |
| Amlodipine besylate; Hydrochlorothiazide; Valsartan | Initial report | 23.02.2026 | Other | Amlodipine/Valsartan/HCT Holsten 10 mg/160 mg/25 mg film-coated tablets | |
| Primidone | Change notification | 23.02.2026 | Other | Primidone Holsten |
Co-trimoxazole 40mg/200mg/5ml oral suspension SF will be out of stock from mid-March to June 2026. The 80mg/400mg/5ml suspension is also unavailable (resupply TBC). The 80mg/400mg and 160mg/800mg tablets remain available. Unlicensed suspension may be sourced, lead times vary.
Source: Community Pharmacy England
Infection and infectious diseases Paediatric and neonatal medicine
| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Mitoxantrone Hydrochloride | Mitron Injection (Mitoxantrone Hydrochloride) | Solution for Injection | Supply Discontinuation | 2026-02-27 |
| Meglumine, Sodium Hydroxide, Amidotrizoic Acid | Gastrografin | Oral Solution | Supply Discontinuation | 2026-02-26 |
| Phentermine Hydrochloride | Phentermine Hydrochloride Extended-Release Capsules 30 Milligrams | Extended-Release Capsule, Pellet | Supply Shortage | 2026-02-25 |
| Diazepam | Daewon Diazepam Tablets 2 Milligrams (Export Name: Diazepam Tablets 2 Milligrams) (Export Name 2: Trezcon Tablets 2 Milligrams) | Najeong | Supply Discontinuation | 2026-02-20 |
| Hydrogen Peroxide, Benzoyl, Clindamycin Phosphate | Duac Gel 5% | Dermatological Gel | Supply Discontinuation | 2026-02-19 |
| Microlanzapine | Zyprexa Zydis Extended-Release Tablets 5 Milligrams (Olanzapine) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Microlanzapine | Zyprexa Zyidis Extended-Release Tablets 10 milligrams (olanzapine) | Oral Disintegrating Tablet | Supply Shortage | 2026-02-13 |
| Bacillus licheniformis, Calcium Pantothenate | Zangidarak Capsule | Hard Capsule, Acid-Resistant | Supply Discontinuation | 2026-02-12 |
| Bemiparin Sodium | Zyber 3500 IU AntiXa/0.2 mL (Sodium Bemiparin) | Solution for Injection | Supply Discontinuation | 2026-02-10 |
| Bemiparin Sodium | Zyber Injection 2500 IU AntiXa/0.2 mL (Vemiparin Sodium) | Solution for Injection | Supply Discontinuation | 2026-02-10 |
| Pimozide | Mingyin Pimozide Tablets 4 milligrams | Najeong | Supply Discontinuation | 2026-02-04 |
| Cisplatin | Unistin Injection 1mg/mL (Cisplatin) (Export Names: Newplatin Inj. 1mg/mL, Cytosplat Inj. 1mg/mL, Nextin Inj. 1mg/mL, Kupunistin Inj. 1mg/mL, KU Cisplatin Inj. 50mg/50mL) | Solution for Injection | Supply Discontinuation | 2026-02-03 |
| Nimodipine | Samjin Nimodipine Injection 10 Milligrams (Export Name: Moditoplinjection) | Solution for Injection | Supply Shortage | 2026-02-03 |
| Cisplatin | Unistin Injection 0.5mg/mL (Cisplatin) (Export Name: Newplatin Inj. 0.5mg/mL, Cytosplat Inj. 0.5mg/mL, Nextin Inj. 0.5mg/mL, KU Cisplatin Inj. 0.5mg/mL | Solution for Injection | Supply Discontinuation | 2026-02-03 |
| Isosorbide Dinitrate Sustained-Release Granules | Bukwang Isomac Sustained-Release Capsules (Isosorbide Dinitrate Sustained-Release Granules) | Extended-Release Capsule, Pellet | Supply Discontinuation | 2026-02-02 |
| Polysaccharide Iron Chelate | Hemonia Capsule (Polysaccharide Iron Chelate) | Hard Capsule, Acid-Resistant | Supply Discontinuation | 2026-01-30 |
| Sodium Fosphenytoin | Serebix Injection (Sodium Fosphenytoin) | Solution for Injection | Supply Discontinuation | 2026-01-30 |
| Sodium Fosphenytoin | Serebix Injection (Sodium Fosphenytoin) | Solution for Injection | Supply Discontinuation | 2026-01-30 |
| Fluvastatin Sodium | Rescol XL Extended-Release Tablets (Fluvastatin Sodium) | Extended-Release Film-Coated Tablets | Supply Discontinuation | 2026-01-29 |
| Haloperidol Decanoate | Haloperidol Decanoate Injection (Haloperidol Decanoate) | Solution for Injection | Supply Shortage | 2026-01-28 |
| Talazoparib Tosylate | Talzena Capsule 1 Milligram (Talazoparib Tosylate) | Hard Capsule, Acid-Resistant | Supply Discontinuation | 2026-01-28 |
| Bacillus licheniformis, Calcium Pantothenate | Biscanbisan | Powder | Supply Discontinuation | 2026-01-28 |
| Human Papillomavirus-16 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4449), Human Papillomavirus-18 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4450) | Suvarix Prefilled Syringe [Human Papillomavirus Vaccine (Recombinant)] | Suspension for Injection | Supply Discontinuation | 2026-01-23 |
| Sodium Bicarbonate | Daewon Sodium Bicarbonate Injection (8.4%) | Solution for Injection | Supply Shortage | 2026-01-22 |
| Ketorolac Tromethamine | Acuveil Eye Drops 0.45% (Ketorolac Tromethamine) (Single-Use) | Eye Drops | Supply Shortage | 2026-01-21 |
| Vinblastine Sulfate | Vinblastine Sulfate Injection | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Mequitazine | Primaran Tablets (Mequitazine) | Najeong | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution Injection | Supply Discontinuation | 2026-01-15 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50 milligrams (Dilazep Hydrochloride Hydrate) | Film-coated tablet | Supply Discontinuation | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated tablet | Supply Shortage | 2026-01-14 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Dexketoprofen Trometamol | Keral (Dexketoprofen Trometamol) | Solution for Injection | Supply Discontinuation | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated tablet | Supply Discontinuation | 2026-01-05 |
| Nalbuphine Hydrochloride | Hanabupine Hydrochloride Injection 10 Milligrams | Solution for Injection | Supply Discontinuation | 2026-01-05 |
| Active ingredients | Status | Update | Specialty |
| valproic acid, sodium (valproate) | Return to availability | 27/02/2026 | Micropakine L.P. 750 mg, extended-release granules in single-dose sachets |
| valproic acid, sodium (valproate) | Supply tension | 27/02/2026 | Micropakine L.P. 250 mg, 500 mg, 1,000 mg, extended-release granules in single-dose sachets |
| Partially hydrolyzed and succinylated modified fluid gelatin | Supply tension | 26/02/2026 | Plasmion, solution for infusion |
| sodium (oxybate) | Supply tension | 26/02/2026 | Specialties containing sodium oxybate 500 mg/mL, oral solution |
| methylphenidate | Return to availability | 26/02/2026 | Quasym LP, modified-release capsule |
| interferon gamma-1b | Stock shortage | 26/02/2026 | Imukin 2 X 10p6 IU (0.1 mg), injectable solution |
| hydrocortisone (hydrogen succinate) | Supply tension | 25/02/2026 | Hydrocortisone Substipharm 100 mg, lyophilisate (vial) and solution for parenteral use |
| olipudase alfa | Supply tension | 23/02/2026 | Xenpozyme 20 mg, powder for solution for dilution for infusion |
| amoxicillin sodium, potassium (clavulanate) | Supply tension | 23/02/2026 | Levmentin 1 g/200 mg, powder for solution for injection/infusion (IV) |
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
| human menopausal gonadotrophin | Injection, powder for | 600 IU | Resolved | Available | Manufacturing | 2/03/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Limited Availability | Manufacturing | 2/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Injection, solution | 260 mg/mL~40 mg/mL | Current | Unavailable | Manufacturing | 2/03/2026 |
| sodium amidotrizoate~amidotrizoate meglumine | Injection, intravenous infusion | 40 mg/mL~260 mg/mL | Current | Unavailable | Manufacturing | 2/03/2026 |
| amlodipine besilate~hydrochlorothiazide~olmesartan medoxomil | Tablet, film coated | 13.9 mg~12.5 mg~40 mg | Anticipated | Available | Manufacturing | 2/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Oral Liquid, solution | 66 g~10 g | Current | Unavailable | Manufacturing | 2/03/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 2/03/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Unexpected increase in consumer demand | 2/03/2026 |
| human menopausal gonadotrophin | Injection, powder for | 1200 IU | Resolved | Available | Manufacturing | 2/03/2026 |
| atomoxetine hydrochloride | Capsule, hard | 20.57 mg | Resolved | Available | Manufacturing | 2/03/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| ropivacaine hydrochloride | Injection, solution | 400 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 2/03/2026 |
| flecainide acetate | Tablet, uncoated | 50 mg | Current | Unavailable | Manufacturing | 2/03/2026 |
| sodium chloride | Injection, solution | .45 g | Current | Unavailable | Commercial Changes / Commercial viability | 2/03/2026 |
| Somatropin | Injection, powder for | 5 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 2/03/2026 |
| rasagiline mesilate | Tablet | 1.56 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| crisaborole | Ointment | 2 % w/w | Current | Limited Availability | Unexpected increase in consumer demand | 27/02/2026 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| moclobemide | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| mirtazapine | Tablet, orally disintegrating | 45 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Manufacturing | 27/02/2026 |
| trandolapril | Capsule | 4 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| trandolapril | Capsule | 2 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 27/02/2026 |
| deferasirox | Tablet, film coated | 180 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| cabazitaxel | Injection, concentrated | 60 mg | Resolved | Available | Manufacturing | 27/02/2026 |
| lamotrigine | Tablet, chewable | 50 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| risperidone | Tablet, film coated | 3 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Current | Unavailable | Manufacturing | 27/02/2026 |
| valaciclovir hydrochloride | Tablet, film coated | 611.22 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| valaciclovir hydrochloride | Tablet, film coated | 611.22 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| moxonidine | Tablet, film coated | 200 microgram | Anticipated | Available | Unexpected increase in consumer demand | 27/02/2026 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| phenobarbital | Tablet, uncoated | 30 mg | Resolved | Available | Manufacturing | 27/02/2026 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Resolved | Available | Manufacturing | 27/02/2026 |
| candesartan cilexetil~hydrochlorothiazide | Tablet | 32 mg~25 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/02/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| lamotrigine | Tablet, chewable | 25 mg | Resolved | Available | Manufacturing | 27/02/2026 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| olanzapine | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 27/02/2026 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| clobetasol propionate | Application | .05 % w/v | Resolved | Available | Unexpected increase in consumer demand | 27/02/2026 |
| irbesartan | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| bimatoprost | Eye Drops | .3 mg/mL | Resolved | Available | Manufacturing | 27/02/2026 |
| lanreotide acetate | Injection, solution | 66.67 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 27/02/2026 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 27/02/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 20.51 mg~16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 27/02/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Unexpected increase in consumer demand | 27/02/2026 |
| daunorubicin hydrochloride | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 2 mg/mL | Current | Unavailable | Manufacturing | 27/02/2026 |
| cetrimide~chlorhexidine gluconate | Solution, irrigation | 45 mg~4.5 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| ziprasidone hydrochloride monohydrate | Capsule, hard | 22.65 mg | Anticipated | Available | Manufacturing | 27/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 2 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 27/02/2026 |
| mupirocin calcium | Cream | 21.5 mg/g | Current | Limited Availability | Manufacturing | 27/02/2026 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 27/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 27/02/2026 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 27/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 27/02/2026 |
| cetrimide~chlorhexidine gluconate | Solution, irrigation | 150 mg~15 mg | Current | Limited Availability | Manufacturing | 27/02/2026 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 12.5 mg~40 mg | Current | Unavailable | Manufacturing | 26/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 26/02/2026 |
| stiripentol | Capsule | 500 mg | Resolved | Available | Manufacturing | 26/02/2026 |
| live varicella vaccine | Injection, powder for | 4000 PFU/mL | Current | Only available under NIP or government programs | Unexpected increase in consumer demand | 26/02/2026 |
| cinacalcet hydrochloride | Tablet, film coated | 99 mg | Current | Unavailable | Manufacturing | 26/02/2026 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Current | Limited Availability | Unexpected increase in consumer demand | 26/02/2026 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 26/02/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 26/02/2026 |
| naratriptan hydrochloride | Tablet, film coated | 2.78 mg | Resolved | Available | Manufacturing | 26/02/2026 |
| gabapentin | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 26/02/2026 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 26/02/2026 |
| alprostadil | Injection, powder for | 40 microgram/mL | Current | Limited Availability | Manufacturing | 26/02/2026 |
| dapsone | Tablet, uncoated | 25 mg | Anticipated | Available | Manufacturing | 26/02/2026 |
| rifabutin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 26/02/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 26/02/2026 |
| dapsone | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 26/02/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 26/02/2026 |
| deferasirox | Tablet, film coated | 180 mg | Current | Limited Availability | Manufacturing | 26/02/2026 |
| dimethyl fumarate | Capsule, enteric | 240 mg | Current | Unavailable | Manufacturing | 26/02/2026 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Manufacturing | 26/02/2026 |
| desmopressin acetate | Spray, solution | .1 mg/mL | Current | Unavailable | Product recall | 25/02/2026 |
| carbetocin | Injection, solution | 100 microgram/mL | Anticipated | Available | Manufacturing | 25/02/2026 |
| cisatracurium besilate | Injection, solution | 7.04 mg | Resolved | Available | Manufacturing | 25/02/2026 |
| betahistine dihydrochloride | Tablet, uncoated | 16 mg | Resolved | Available | Unexpected increase in consumer demand | 25/02/2026 |
| olanzapine | Tablet, orally disintegrating | 10 mg | Current | Limited Availability | Manufacturing | 25/02/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.688 mg | Current | Limited Availability | Manufacturing | 25/02/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Limited Availability | Manufacturing | 25/02/2026 |
| azacitidine | Injection, powder for | 100 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 25/02/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.844 mg | Current | Limited Availability | Manufacturing | 25/02/2026 |
| perindopril erbumine~indapamide hemihydrate | Tablet | 4 mg~1.25 mg | Current | Unavailable | Manufacturing | 25/02/2026 |
| lamivudine | Tablet, film coated | 300 mg | Current | Unavailable | Manufacturing | 25/02/2026 |
| avanafil | Tablet, uncoated | 200 mg | Resolved | Available | Unexpected increase in consumer demand | 25/02/2026 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~86.751 mg | Current | Limited Availability | Manufacturing | 25/02/2026 |
| risperidone | Tablet, film coated | 3 mg | Current | Unavailable | Manufacturing | 25/02/2026 |
| levothyroxine sodium | Tablet, uncoated | .2 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 25/02/2026 |
| Hepatitis B surface antigen recombinant | Injection, suspension | 40 microgram/mL | Anticipated | Available | Unexpected increase in consumer demand | 25/02/2026 |
| gabapentin | Capsule, hard | 400 mg | Resolved | Available | Manufacturing | 25/02/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 25/02/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 10 mg | Current | Unavailable | Manufacturing | 25/02/2026 |
| telmisartan~amlodipine besilate | Tablet, multilayer | 40 mg~6.935 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| lacosamide | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 24/02/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Resolved | Available | Manufacturing | 24/02/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Resolved | Available | Unexpected increase in consumer demand | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, multilayer | 6.935 mg~80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| clonidine hydrochloride | Injection, solution | 150 microgram/mL | Current | Limited Availability | Unexpected increase in consumer demand | 24/02/2026 |
| entacapone~carbidopa monohydrate~levodopa | Tablet, film coated | 200 mg~27 mg~100 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 24/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 20 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 24/02/2026 |
| olipudase alfa | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 24/02/2026 |
| flunitrazepam | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 24/02/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 24/02/2026 |
| telmisartan~amlodipine besilate | Tablet, multilayer | 40 mg~13.87 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| lamotrigine | Tablet, dispersible | 200 mg | Resolved | Available | Manufacturing | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, multilayer | 6.935 mg~80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, multilayer | 13.87 mg~40 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| nizatidine | Capsule | 300 mg | Resolved | Available | Manufacturing | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, multilayer | 13.87 mg~80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| telmisartan~amlodipine besilate | Tablet, multilayer | 40 mg~6.935 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 24/02/2026 |
| sunitinib | Capsule | 25 mg | Anticipated | Available | Manufacturing | 24/02/2026 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 24/02/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 126.83 mg | Current | Limited Availability | Manufacturing | 24/02/2026 |
| aprepitant | Capsule, hard | 165 mg | Anticipated | Available | Manufacturing | 24/02/2026 |
| bromocriptine mesilate | Tablet, uncoated | 2.87 mg | Current | Unavailable | Manufacturing | 24/02/2026 |
| peramivir | Injection, concentrated | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 24/02/2026 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, multilayer | 13.87 mg~80 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| drospirenone~ethinylestradiol | Tablet | 3 mg~30 microgram | Current | Limited Availability | Manufacturing | 24/02/2026 |
| cabergoline | Tablet, uncoated | 2 mg | Anticipated | Available | Manufacturing | 24/02/2026 |
| silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 40 mg~6.935 mg | Discontinued | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 24/02/2026 |
| telmisartan~amlodipine besilate | Tablet, film coated | 80 mg~13.87 mg | Discontinued | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 6.935 mg~80 mg | Discontinued | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 24/02/2026 |
| amlodipine besilate~telmisartan | Tablet, film coated | 13.87 mg~40 mg | Discontinued | Reduction in supply until supply is exhausted | Unexpected increase in consumer demand | 24/02/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 24/02/2026 |
| silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 24/02/2026 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 54.1 mg~200 mg~200 mg | Current | Unavailable | Unexpected increase in consumer demand | 24/02/2026 |
| fluorouracil | Injection, solution | 50 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/02/2026 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/02/2026 |
| aripiprazole | Tablet, uncoated | 20 mg | Anticipated | Available | Manufacturing | 23/02/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 23/02/2026 |
| olipudase alfa | Injection, powder for | 4 mg | Resolved | Available | Manufacturing | 23/02/2026 |
| rifampicin | Capsule | 150 mg | Resolved | Available | Manufacturing | 23/02/2026 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/02/2026 |
| simvastatin~ezetimibe | Tablet | 40 mg~10 mg | Current | Limited Availability | Manufacturing | 23/02/2026 |
| simvastatin | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 23/02/2026 |
| nicorandil | Tablet, uncoated | 20 mg | Resolved | Available | Manufacturing | 23/02/2026 |
| tobramycin | Injection, solution | 80 mg | Resolved | Available | Manufacturing | 23/02/2026 |
| alprostadil | Injection, powder for | 20 microgram/mL | Resolved | Available | Unexpected increase in consumer demand | 23/02/2026 |
| atomoxetine hydrochloride | Capsule, hard | 11.43 mg | Current | Unavailable | Manufacturing | 23/02/2026 |
| rifampicin | Capsule | 300 mg | Current | Limited Availability | Manufacturing | 23/02/2026 |
| formoterol fumarate | Inhalation, powder for | 12 microgram | Current | Limited Availability | Manufacturing | 23/02/2026 |
| Generic Name | Shortage Status | Revision Date |
| Methylphenidate Immediate-Release Tablets | Current Shortages | 27-Feb-26 |
| Oseltamivir Oral Suspension and Capsules | Current Shortages | 27-Feb-26 |
| Penicillin V Potassium Oral Presentations | Current Shortages | 27-Feb-26 |
| Physostigmine Salicylate Injection | Current Shortages | 27-Feb-26 |
| Clindamycin Phosphate Injection | Current Shortages | 25-Feb-26 |
| Furosemide Oral Solution | Current Shortages | 25-Feb-26 |
| Vasopressin Injection | Current Shortages | 25-Feb-26 |
| Dorzolamide Ophthalmic Solution | Current Shortages | 24-Feb-26 |
| Dronabinol Capsules | Current Shortages | 24-Feb-26 |
| Hydromorphone Immediate-Release Oral Presentations | Current Shortages | 24-Feb-26 |
| Epoprostenol Injection | Current Shortages | 23-Feb-26 |
| Methylphenidate Extended Release Oral Presentations | Current Shortages | 23-Feb-26 |
| Octreotide Intramuscular Injection Kits | Current Shortages | 23-Feb-26 |
| Prednisone Oral Tablets | Current Shortages | 23-Feb-26 |
| Ropivacaine Injection | Current Shortages | 23-Feb-26 |

